Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Research graph
References from Stereotactic body radiotherapy (SBRT) for locally advanced extrahepatic and intrahepatic cholangiocarcinoma. Local targets link to admitted publications; unresolved targets remain external evidence.
Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution
10.1097/01.sla.0000251366.62632.d3 · 2007 · External reference
Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States
10.1093/jnci/djj234 · 2006 · External reference
Recent advances in the management of cholangiocarcinomas
10.1055/s-2007-1007302 · 1994 · External reference
“Natural history” of unresected cholangiocarcinoma: patient outcome after noncurative intervention
10.4065/70.5.425 · 1995 · External reference
Role of radiation after operative palliation in cancer of the proximal bile ducts
10.1016/0002-9610(91)91111-u · 1991 · External reference
Radiotherapy is associated with improved survival in adjuvant and palliative treatment of extrahepatic cholangiocarcinomas
10.1016/j.ijrobp.2008.09.017 · 2009 · External reference
Chemoradiation and brachytherapy in biliary tract carcinoma: Long-term results
10.1016/j.ijrobp.2005.07.977 · 2006 · External reference
Clinical outcomes and toxicity using stereotactic body radiotherapy (SBRT) for advanced cholangiocarcinoma
10.1186/1748-717x-7-67 · 2012 · External reference
Ablative radiotherapy doses lead to a substantial prolongation of survival in patients with inoperable intrahepatic cholangiocarcinoma: A retrospective dose response analysis
10.1200/jco.2015.61.3778 · 2016 · External reference
A dosimetric model of duodenal toxicity after stereotactic body radiotherapy for pancreatic cancer
10.1016/j.ijrobp.2009.09.075 · 2010 · External reference
A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases
10.1016/j.ijrobp.2005.01.002 · 2005 · External reference
Stereotactic body radiation therapy for abdominal and pelvic oligometastases: Dosimetric targets for safe and effective local control
10.1016/j.prro.2014.09.006 · 2015 · External reference
Acceptable toxicity after stereotactic body radiation therapy for liver tumors adjacent to the central biliary system
10.1016/j.ijrobp.2012.09.012 · 2013 · External reference
Limitations of conventional doses of chemoradiation for unresectable biliary cancer
10.1016/s0360-3016(02)02845-6 · 2002 · External reference
External-beam radiotherapy for localized extrahepatic cholangiocarcinoma
10.1016/j.ijrobp.2006.05.061 · 2006 · External reference
Stereotactic body radiotherapy for unresectable cholangiocarcinoma
10.1016/j.radonc.2009.11.004 · 2010 · External reference
Prognostic factors affecting local control of hepatic tumors treated by stereotactic body radiation therapy
10.1186/1748-717x-7-166 · 2012 · External reference
Chemoradiation treatment with gemcitabine plus stereotactic body radiotherapy for unresectable, non-metastatic, locally advanced hilar cholangiocarcinoma. Results of a five year experience
10.1016/j.radonc.2011.05.016 · 2011 · External reference
Outcomes of stereotactic body radiotherapy for unresectable primary or recurrent cholangiocarcinoma
10.3857/roj.2014.32.3.163 · 2014 · External reference
The role of radiotherapy and chemoradiation in the management of primary liver tumours
10.1016/j.clon.2014.05.016 · 2014 · External reference
Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization
10.1002/cncr.27533 · 2012 · External reference
Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma
10.1002/cncr.29161 · 2015 · External reference
Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers
10.1053/j.gastro.2012.04.008 · 2012 · External reference
Neoadjuvant stereotactic body radiation therapy, capecitabine, and liver transplantation for unresectable hilar cholangiocarcinoma
10.1002/lt.23757 · 2014 · External reference
Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: A 24-year experience in a single center
10.1001/archsurg.2011.116 · 2011 · External reference